Dilyx Biotechnologies Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Dilyx Biotechnologies General Information

Description

Operator of a biotechnology company. The company develops analysis kits for a range of life-science research applications. Its products include the OptiSol Protein Solubility Screening Kit, designed to allow research scientists to aggregation-proof their protein samples.

Contact Information

Website
www.dilyx.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 815 1st Avenue
  • Seattle, WA 98104
  • United States
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Laboratory Services (Healthcare)
Acquirer
Vertical(s)
Corporate Office
  • 815 1st Avenue
  • Seattle, WA 98104
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dilyx Biotechnologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dilyx Biotechnologies‘s full profile, request access.

Request a free trial

Dilyx Biotechnologies Patents

Dilyx Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20110312506-A1 Methods and kits for screening protein solubility Inactive 17-Jun-2010

Dilyx Biotechnologies FAQs

  • When was Dilyx Biotechnologies founded?

    Dilyx Biotechnologies was founded in 2010.

  • Where is Dilyx Biotechnologies headquartered?

    Dilyx Biotechnologies is headquartered in Seattle, WA.

  • What industry is Dilyx Biotechnologies in?

    Dilyx Biotechnologies’s primary industry is Discovery Tools (Healthcare).

  • Is Dilyx Biotechnologies a private or public company?

    Dilyx Biotechnologies is a Private company.

  • What is Dilyx Biotechnologies’s current revenue?

    The current revenue for Dilyx Biotechnologies is .

  • When was Dilyx Biotechnologies acquired?

    Dilyx Biotechnologies was acquired on 02-Oct-2014.

  • Who acquired Dilyx Biotechnologies?

    Dilyx Biotechnologies was acquired by Soluble Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »